| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
3 companies
Pharis Mohideen is Chief Medical Officer at DBVT and has filed Form 4s across 3 companies. From December 2018 to July 2026, the filings on record show 0 open-market purchases and 12 sales. Pharis Mohideen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.8M at current prices.
Historically, Pharis Mohideen's trades have earned a below-average insider score of 47/100 across 15 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -45.1%.
The biggest single holding is DBVT (~$1.5M) as Chief Medical Officer. The DBVT filings lean toward selling, a net 20,705 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2023 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 2,245 | $1.74 | $3,906.30 | -2.7% | -1.8% | -69.5% | |
| May 24, 2023 | DBVT Dbv Technologies S.A. | Chief Medical Officer | Sell | 2,261 | $3.02 | $6,821.22 | -4.4% | -21.7% | -67.5% |